|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Chemotherapy in non-small cell lung
cancer: A meta-analysis using updated data on individual patients
from 52 randomised clinical trials. Non-small cell lung cancer
collaborative group. BMJ. 311:899–909. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Filipits M, Pirker R, Dunant A, Lantuejoul
S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, et
al: Cell cycle regulators and outcome of adjuvant cisplatin-based
chemotherapy in completely resected non-small-cell lung cancer: The
international adjuvant lung cancer trial biologic program. J Clin
Oncol. 25:2735–2740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mamdani H, Induru R and Jalal SI: Novel
therapies in small cell-lung cancer. Transl Lung Cancer Res.
4:533–544. 2015.PubMed/NCBI
|
|
5
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
6
|
Mendoza JL, Urcelay E, Lana R, Martín MC,
López N, Guijarro LG, Mayol JA, Taxonera C, de la Concha EG, Peña
AS and Díaz-Rubio M: MDR1 polymorphisms and response to
azathioprine therapy in patients with Crohn's disease. Inflamm
Bowel Dis. 13:585–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bisbal C, Martinand C, Silhol M, Lebleu B
and Salehzada T: Cloning and characterization of a RNase L
inhibitor. A new component of the interferon-regulated 2–5 A
pathway. J Biol Chem. 270:13308–13317. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hassel BA, Zhou A, Sotomayor C, Maran A
and Silverman RH: A dominant negative mutant of 2–5A-dependent
RNase suppresses antiproliferative and antiviral effects of
interferon. EMBO J. 12:3297–3304. 1993.PubMed/NCBI
|
|
9
|
Le Roy F, Bisbal C, Silhol M, Martinand C,
Lebleu B and Salehzada T: The 2–5A/RNase L/RNase L inhibitor (RLI)
[correction of (RNI)] pathway regulates mitochondrial mRNAs
stability in interferon alpha-treated H9 cells. J Biol Chem.
276:48473–48482. 2001.PubMed/NCBI
|
|
10
|
Chen ZQ, Dong J, Ishimura A, Daar I,
Hinnebusch AG and Dean M: The essential vertebrate ABCE1 protein
interacts with eukaryotic initiation factors. J Biol Chem.
281:7452–7457. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pisareva VP, Skabkin MA, Hellen CU,
Pestova TV and Pisarev AV: Dissociation by Pelota, Hbs1 and ABCE1
of mammalian vacant 80S ribosomes and stalled elongation complexes.
EMBO J. 30:1804–1817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang B, Gao Y, Tian D and Zheng M: A
small interfering ABCE1-targeting RNA inhibits the proliferation
and inva-siveness of small cell lung cancer. Int J Mol Med.
25:687–693. 2010.PubMed/NCBI
|
|
13
|
Ren Y, Li Y and Tian D: Role of the ABCE1
gene in human lung adenocarcinoma. Oncol Rep. 27:965–970.
2012.PubMed/NCBI
|
|
14
|
Hlavata I, Mohelnikova-Duchonova B,
Vaclavikova R, Liska V, Pitule P, Novak P, Bruha J, Vycital O,
Holubec L, Treska V, et al: The role of ABC transporters in
progression and clinical outcome of colorectal cancer. Mutagenesis.
27:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: MiR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
16
|
Tian Y, Han X and Tian DL: The biological
regulation of ABCE1. IUBMB Life. 64:795–800. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang B, Zhou H, Lang X and Liu Z:
SiRNA-induced ABCE1 silencing inhibits proliferation and invasion
of breast cancer cells. Mol Med Rep. 10:1685–1690. 2014.PubMed/NCBI
|
|
18
|
Wang L, Zhang M and Liu DX: Knock-down of
ABCE1 gene induces G1/S arrest in human oral cancer cells. Int J
Clin Exp Pathol. 7:5495–5504. 2014.PubMed/NCBI
|
|
19
|
Tian Y, Tian X, Han X, Chen Y, Song CY,
Jiang WJ and Tian DL: ABCE1 plays an essential role in lung cancer
progression and metastasis. Tumor Biol. Jan 5–2016.Epub ahead of
print. View Article : Google Scholar
|
|
20
|
Nürenberg E and Tampé R: Tying up loose
ends: Ribosome recycling in eukaryotes and archaea. Trends Biochem
Sci. 38:64–74. 2013. View Article : Google Scholar
|
|
21
|
Franckenberg S, Becker T and Beckmann R:
Structural view on recycling of archaeal and eukaryotic ribosomes
after canonical termination and ribosome rescue. Curr Opin Struct
Biol. 22:786–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khoshnevis S, Gross T, Rotte C, Baierlein
C, Ficner R and Krebber H: The iron-sulphur protein RNase L
inhibitor functions in translation termination. EMBO Rep.
11:214–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yasui K, Mihara S, Zhao C, Okamoto H,
Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, et
al: Alteration in copy numbers of genes as a mechanism for acquired
drug resistance. Cancer Res. 64:1403–1410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slingerland J and Pagano M: Regulation of
the cdk inhibitor p27 and its deregulation in cancer. J Cell
Physiol. 183:10–17. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: Prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esposito V, Baldi A, De Luca A, Groger AM,
Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A:
Prognostic role of the cyclin-dependent kinase Inhibitor p27 in
non-small cell lung cancer. Cancer Res. 57:3381–3385.
1997.PubMed/NCBI
|
|
27
|
Chen J, Willingham T, Shuford M and Nisen
PD: Tumor suppression and inhibition of aneuploid cell accumulation
in human brain tumor cells by ectopic overexpression of the
cyclin-dependent kinase inhibitor p27KIP1. J Clin Invest.
97:1983–1988. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Díez-Juan A and Andrés V: Coordinate
control of proliferation and migration by the
p27kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular
smooth muscle cells and fibroblasts. Circ Res. 92:402–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Supriatno, Harada K, Kawaguchi S, Yoshida
H and Sato M: Effect of p27Kip1 on the ability of invasion and
metastasis of an oral cancer cell line. Oncol Rep. 10:527–532.
2003.PubMed/NCBI
|
|
30
|
Alhebshi A, Sideri TC, Holland SL and
Avery SV: The essential iron-sulfur protein Rli1 is an important
target accounting for inhibition of cell growth by reactive oxygen
species. Mol Biol Cell. 23:3582–3590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhai C, Li Y, Mascarenhas C, et al: The
function of ORAOV1/LTO1, a gene that is overexpressed frequently in
cancer: Essential roles in the function and biogenesis of the
ribosome. Oncogene. 33:484–494. 2014. View Article : Google Scholar
|
